23/10/2026
PARALLEL-IMPORTED BOTULINUM TOXINS ARE BEING USED IN SOUTH AFRICA. SHOULD PATIENTS BE CONCERNED?
The increasing discussion around parallel-imported toxins in aesthetic medicine raises an important question: How certain are we about the products being injected into patients?
Botulinum toxin should produce controlled, predictable muscle relaxation. But what happens when muscles we never intended to treat become affected?
Unexpected muscle relaxation may result in:
* Drooping eyelids or eyebrows
* Facial asymmetry and an altered smile
* Weakness in surrounding muscles
* Unnatural facial expressions
* Functional complications, including difficulty speaking or swallowing in more serious cases
Here is what patients need to understand.
These complications can occur even with authorised products. Injection technique, dosage, individual anatomy and toxin spread all influence the outcome.
However, products sourced through unverified supply channels raise additional concerns about authenticity, potency, storage and quality control.
Parallel importation itself does not automatically mean a product is unsafe but it can definitely be. Proper regulatory authorisation and product traceability are essential.
In aesthetic medicine, precision is everything.
The goal isn’t simply to relax muscles. It’s to relax the RIGHT muscles, at the RIGHT dose, while preserving natural movement and expression.
Know your injector. Know your product. Never compromise on safety.